Académique Documents
Professionnel Documents
Culture Documents
CASE STUDY
Session 3: Applying sampling procedures in test of controls
ANNEX 2
Population of RIS for drugs and medicines
January to June 2016
RIS No. Date RIS No. Date RIS No. Date RIS No. Date
16-0001 1/7/16 16-0042 2/4/16 16-0083 2/18/16 16-0124 3/10/16
16-0002 1/7/16 16-0043 2/4/16 16-0084 2/18/16 16-0125 3/10/16
16-0003 1/7/16 16-0044 2/4/16 16-0085 2/18/16 16-0126 3/10/16
16-0004 1/7/16 16-0045 2/4/16 16-0086 2/18/16 16-0127 3/10/16
16-0005 1/7/16 16-0046 2/4/16 16-0087 2/18/16 16-0128 3/10/16
16-0006 1/7/16 16-0047 2/4/16 16-0088 2/18/16 16-0129 3/10/16
16-0007 1/14/16 16-0048 2/4/16 16-0089 2/18/16 16-0130 3/10/16
16-0008 1/14/16 16-0049 2/4/16 16-0090 2/18/16 16-0131 3/10/16
16-0009 1/14/16 16-0050 2/4/16 16-0091 2/18/16 16-0132 3/10/16
16-0010 1/14/16 16-0051 2/4/16 16-0092 2/18/16 16-0133 3/10/16
16-0011 1/14/16 16-0052 2/4/16 16-0093 2/18/16 16-0134 3/10/16
16-0012 1/14/16 16-0053 2/4/16 16-0094 2/18/16 16-0135 3/10/16
16-0013 1/21/16 16-0054 2/4/16 16-0095 2/18/16 16-0136 3/10/16
16-0014 1/21/16 16-0055 2/4/16 16-0096 2/18/16 16-0137 3/10/16
16-0015 1/21/16 16-0056 2/4/16 16-0097 2/18/16 16-0138 3/10/16
16-0016 1/21/16 16-0057 2/4/16 16-0098 2/25/16 16-0139 3/17/16
16-0017 1/21/16 16-0058 2/4/16 16-0099 2/25/16 16-0140 3/17/16
16-0018 1/21/16 16-0059 2/4/16 16-0100 2/25/16 16-0141 3/17/16
16-0019 1/21/16 16-0060 2/4/16 16-0101 2/25/16 16-0142 3/17/16
16-0020 1/21/16 16-0061 2/4/16 16-0102 2/25/16 16-0143 3/17/16
16-0021 1/21/16 16-0062 2/4/16 16-0103 2/25/16 16-0144 3/17/16
16-0022 1/28/16 16-0063 2/4/16 16-0104 2/25/16 16-0145 3/17/16
16-0023 1/28/16 16-0064 2/4/16 16-0105 2/25/16 16-0146 3/17/16
16-0024 1/28/16 16-0065 2/4/16 16-0106 2/25/16 16-0147 3/17/16
16-0025 1/28/16 16-0066 2/4/16 16-0107 2/25/16 16-0148 3/17/16
16-0026 1/28/16 16-0067 2/4/16 16-0108 2/25/16 16-0149 3/17/16
16-0027 1/28/16 16-0068 2/11/16 16-0109 2/25/16 16-0150 3/17/16
16-0028 1/28/16 16-0069 2/11/16 16-0110 2/25/16 16-0151 3/17/16
16-0029 1/28/16 16-0070 2/11/16 16-0111 2/25/16 16-0152 3/17/16
16-0030 1/28/16 16-0071 2/11/16 16-0112 2/25/16 16-0153 3/17/16
16-0031 1/28/16 16-0072 2/11/16 16-0113 2/25/16 16-0154 3/17/16
16-0032 1/28/16 16-0073 2/11/16 16-0114 2/25/16 16-0155 3/17/16
16-0033 1/28/16 16-0074 2/11/16 16-0115 3/3/16 16-0156 3/24/16
16-0034 1/28/16 16-0075 2/11/16 16-0116 3/3/16 16-0157 3/24/16
16-0035 1/28/16 16-0076 2/11/16 16-0117 3/3/16 16-0158 3/24/16
16-0036 1/28/16 16-0077 2/11/16 16-0118 3/3/16 16-0159 3/24/16
16-0037 1/28/16 16-0078 2/11/16 16-0119 3/3/16 16-0160 3/24/16
16-0038 1/28/16 16-0079 2/11/16 16-0120 3/3/16 16-0161 3/31/16
16-0039 1/28/16 16-0080 2/11/16 16-0121 3/3/16 16-0162 3/31/16
16-0040 1/28/16 16-0081 2/11/16 16-0122 3/3/16 16-0163 3/31/16
16-0041 1/28/16 16-0082 2/11/16 16-0123 3/10/16 16-0164 3/31/16
Page 1 of 2
ANNEX 1
Population of RIS for drugs and medicines
January to June 2016
Page 2 of 2